Cowen Inc’s AstraZeneca AZN Stock Holding History

Cowen Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,650	Closed	-$317K	–	228
2017 Q2	$317K	Buy	+4,650	New	+$304K	0.02%	246

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cowen Inc's AZN Position: Q3 2017 in Review

Cowen Inc sold out of AstraZeneca (AZN) in Q3 2017, closing a stake of 1,250 shares — an estimated $85K sold.

Cowen Inc first reported a position in AZN in Q3 2014 and held it in 3 quarters. The position peaked at $607K in Q3 2014. 455 funds tracked by Wall St. Rank hold AZN as of Q3 2017.

Cowen Inc reported no remaining AstraZeneca position as of Q3 2017 after selling out during the quarter.
Cowen Inc sold 1,250 AstraZeneca shares in Q3 2017, an estimated $85K.
Cowen Inc first reported a position in AstraZeneca in Q3 2014 and held it in 3 quarters.
Cowen Inc's AstraZeneca position peaked at $607K in Q3 2014.
455 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2017.

Based on Cowen Inc's 13F filing for Q3 2017, filed 14 Nov 2017.